rs770272088
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PS1PM1PM2PP3_StrongPP5_Very_Strong
The NM_001540.5(HSPB1):c.250G>A(p.Gly84Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000144 in 1,392,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin Lovd.
Frequency
Consequence
NM_001540.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPB1 | NM_001540.5 | c.250G>A | p.Gly84Arg | missense_variant | 1/3 | ENST00000248553.7 | NP_001531.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSPB1 | ENST00000248553.7 | c.250G>A | p.Gly84Arg | missense_variant | 1/3 | 1 | NM_001540.5 | ENSP00000248553.6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1392122Hom.: 0 Cov.: 31 AF XY: 0.00000145 AC XY: 1AN XY: 687784
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2F Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 84 of the HSPB1 protein (p.Gly84Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant HSPB1-related conditions (PMID: 18344398, 18832141, 21892769, 25429913). This variant has been reported in individual(s) with autosomal recessive Charcot-Marie-Tooth disease (PMID: 28379183); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 632006). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on HSPB1 protein function. Experimental studies have shown that this missense change affects HSPB1 function (PMID: 18344398, 23948568). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Aug 11, 2021 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 26, 2022 | This variant has been identified in at least one individual with clinical features associated with Charcot-Marie-Tooth disease. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant results in the same amino acid change as another variant (c.250G>C; p.Gly84Arg) considered to be pathogenic or likely pathogenic, strongly indicating this variant may also cause disease. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant was found to affect protein stability and decrease chaperone activity compared to wild-type resulting in abnormal cytoplasmic aggregation (PMID: 23948568, 31573509). - |
HSPB1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Sep 05, 2017 | The HSPB1 c.250G>A (p.Gly84Arg) missense variant has been reported in two studies and found in a total of three affected individuals, including in a homozygous state in two siblings with distal hereditary motor neuropathy (dHMN) and in a presumed heterozygous state in one individual with Charcot-Marie-Tooth, type 2 (CMT2) (Manganelli et al. 2014; Ho et al. 2017). This variant was also identified in a heterozygous state in both presumably unaffected parents of the homozygous siblings. A second variant at the same nucleotide position, c.250G>C, also results in a p.Gly84Arg amino acid change and has been reported in a total of five individuals, including in a homozygous state in one individual with early onset CMT2, in a heterozygous state in two individuals with dHMN, and in a heterozygous state in the parents of the homozygous individual, both of whom displayed sub-clinical features, (James et al. 2008; Houlden et al. 2008; Fischer et al. 2012). Control data are unavailable for this variant, which is reported at a frequency of 0.000017 in the European (non-Finnish) population of the Genome Aggregation Database, but this is based on one allele in a region of good sequencing coverage so it is presumed to be rare. Expression of the p.Gly84Arg variant in HeLa cells led to abnormal protein aggregation (James et al. 2008), and protein interaction studies revealed that while the p.Gly84Arg variant does not affect neurofilament assembly, it does impact mobility and accessibility of the N-terminal domain, which modifies interdimer contacts in HspB1 oligomers (Nefedova et al. 2013; Nefedova et al. 2017). Based on the collective evidence, the c.250G>A (p.Gly84Arg) variant is classified as likely pathogenic for HSPB1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at